| pubmed-article:7968359 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7968359 | lifeskim:mentions | umls-concept:C0036572 | lld:lifeskim |
| pubmed-article:7968359 | lifeskim:mentions | umls-concept:C1705480 | lld:lifeskim |
| pubmed-article:7968359 | lifeskim:mentions | umls-concept:C0035696 | lld:lifeskim |
| pubmed-article:7968359 | lifeskim:mentions | umls-concept:C0442805 | lld:lifeskim |
| pubmed-article:7968359 | lifeskim:mentions | umls-concept:C0205263 | lld:lifeskim |
| pubmed-article:7968359 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:7968359 | pubmed:issue | 1-4 | lld:pubmed |
| pubmed-article:7968359 | pubmed:dateCreated | 1994-12-7 | lld:pubmed |
| pubmed-article:7968359 | pubmed:abstractText | Neuroendocrine disturbances are among the significant problems associated with animal and human seizures. To investigate the mechanisms for these disturbances, we examined changes in the expression of vasopressin (VP) mRNA in the hypothalamic magnocellular neuroendocrine cells of rats after amygdala kindled seizures, a model for temporal lobe epilepsy. A prominent increase in VP mRNA was found in the supraoptic nucleus of kindled animals by one week after the last seizure which persisted for at least 4 months. The increase occurred bilaterally in the SON and remained unchanged despite the absence of further stimulation, seizures or change in body fluid homeostasis. Since the VP mRNA change after kindling correlated with the duration of afterdischarge but not the number of amygdala stimuli the change appears to be an effect of the seizure. This chronic increase in VP mRNA appears to reflect a change in neuroendocrine gene expression and may identify an important new mechanism of plasticity that contributes to the neuroendocrine disturbances accompanying epilepsy. | lld:pubmed |
| pubmed-article:7968359 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7968359 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7968359 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7968359 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7968359 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7968359 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7968359 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7968359 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7968359 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:7968359 | pubmed:issn | 0169-328X | lld:pubmed |
| pubmed-article:7968359 | pubmed:author | pubmed-author:HaywardJ NJN | lld:pubmed |
| pubmed-article:7968359 | pubmed:author | pubmed-author:MeekerR BRB | lld:pubmed |
| pubmed-article:7968359 | pubmed:author | pubmed-author:GreenwoodR... | lld:pubmed |
| pubmed-article:7968359 | pubmed:author | pubmed-author:AbdouAA | lld:pubmed |
| pubmed-article:7968359 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7968359 | pubmed:volume | 24 | lld:pubmed |
| pubmed-article:7968359 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7968359 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7968359 | pubmed:pagination | 20-6 | lld:pubmed |
| pubmed-article:7968359 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:meshHeading | pubmed-meshheading:7968359-... | lld:pubmed |
| pubmed-article:7968359 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7968359 | pubmed:articleTitle | Kindled seizures induce a long-term increase in vasopressin mRNA. | lld:pubmed |
| pubmed-article:7968359 | pubmed:affiliation | Department of Neurology, University of North Carolina School of Medicine, Chapel Hill 27599. | lld:pubmed |
| pubmed-article:7968359 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7968359 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:7968359 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:7968359 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
